AKTX

AKTX

Akari Therapeutics plc ADS

$1.171+0.000 (0.017%)

Precio en Tiempo Real

Gráfico de Precios

Loading Chart...

Métricas Clave

Métricas de Mercado
Fundamentos de la Empresa
Estadísticas de Negociación

Métricas de Mercado

Apertura

$1.171

Máximo

$1.171

Mínimo

$1.171

Volumen

0.04M

Fundamentos de la Empresa

Estadísticas de Negociación

Noticias Relacionadas

GlobeNewswire

Akari Therapeutics Reports First Quarter 2025 Financial Results and Provides Corporate Update

Advancing development of novel Antibody Drug Conjugates (ADCs) with immuno-oncology payloads to treat multiple cancer tumors Rounding out executive team with deep oncology experience by appointing new Head of Business

Ver más
Akari Therapeutics Reports First Quarter 2025 Financial Results and Provides Corporate Update
GlobeNewswire

Akari Therapeutics Appoints Mark F. Kubik as Head of Business Development - Oncology

Global expertise in establishing and executing transformative transactions which have led to multiple approved therapeutic products Successful track record across oncology therapeutics including ADCs and antibody

Ver más
Akari Therapeutics Appoints Mark F. Kubik as Head of Business Development - Oncology

Mantente Actualizado

Configura alertas de precio, recibe actualizaciones de análisis de IA y noticias de mercado en tiempo real.